Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ

Clinical trial NCT01791374 · COMPLETED

Trial details

NCT number: NCT01791374
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Part 1- Advanced Solid Tumors Part 2- Advanced or Metastatic Gastric Cancer Part 2- Advanced or Metastatic GEJ

Start date: 2012-11-01
Primary completion: 2013-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.